96 related articles for article (PubMed ID: 562722)
1. Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
Takamizawa A; Matsumoto S; Iwata T; Makino I
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1877-91. PubMed ID: 562722
[No Abstract] [Full Text] [Related]
2. Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.
Takamizawa A; Matsumoto S; Iwata T; Makino I; Yamaguchi K; Uchida N; Kasai H; Shiratori O; Takase S
J Med Chem; 1978 Feb; 21(2):208-14. PubMed ID: 621716
[TBL] [Abstract][Full Text] [Related]
3. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
Takamizawa A; Iwata T; Yamaguchi K; Shiratori O; Harada M
Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
Misiura K; Kinas RW; Stec WJ; Kusnierczyk H; Radzikowski C; Sonoda A
J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
Hohorst HJ; Peter G; Struck RF
Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
Kutscher B; Niemeyer U; Engel J; Kleemann A; Hilgard P; Pohl J; Scheffler G
Arzneimittelforschung; 1995 Mar; 45(3):323-6. PubMed ID: 7741794
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
[TBL] [Abstract][Full Text] [Related]
8. Anodic oxidation of ifosfamide and cyclophosphamide: a biomimetic metabolism model of the oxazaphosphorinane anticancer drugs.
Paci A; Martens T; Royer J
Bioorg Med Chem Lett; 2001 May; 11(10):1347-9. PubMed ID: 11392552
[TBL] [Abstract][Full Text] [Related]
9. (S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
Misiura K; Kinas RW; Kuśnierczyk H; Radzikowski C; Stec WJ
Anticancer Drugs; 2001 Jun; 12(5):453-8. PubMed ID: 11395573
[TBL] [Abstract][Full Text] [Related]
10. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumour activity of stereoisomers of 4-hydroperoxy derivatives of ifosfamide and its bromo analogue.
Misiura K; Szymanowicz D; Kusnierczyk H; Wietrzyk J; Opolski A
Farmaco; 2002 Apr; 57(4):315-9. PubMed ID: 11989810
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor properties of activated cyclophosphamide analogues.
Borch RF; Canute GW
J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor evaluation of 4-ethoxycarbonyl cyclophosphamide analogs.
Foster EL
J Pharm Sci; 1978 May; 67(5):709-10. PubMed ID: 641817
[TBL] [Abstract][Full Text] [Related]
16. Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Lelieveld P; van Putten LM
Cancer Treat Rep; 1976 Apr; 60(4):373-9. PubMed ID: 1064468
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of acute toxicity and antitumor activity of IF-XXV preparation and holoxan.
Kuśnierczyk H; Matuszyk J; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):547-56. PubMed ID: 2487366
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide in experimental tumor systems.
Goldin A
Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
[No Abstract] [Full Text] [Related]
20. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Glazman-Kuśnierczyk H; Matuszyk J; Radzikowski C
Immunopharmacol Immunotoxicol; 1992; 14(4):883-911. PubMed ID: 1294626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
